title: Management of Helicobacter pylori infection in ulcer disease.
abstract: Eradication of the bacterium not only heals the ulcer but essentially cures the underlying peptic ulcer disease. Although there is still no simple, all-purpose regimen, a decade of experience has identified safe, well- tolerated drug combinations that yield eradication rates exceeding 90% without generating a high frequency of bacterial resistance.
authors.affiliation: Tufts University School of Medicine, USA.
authors.forename: D R
authors.initials: DR
authors.lastname: Cave
authors.forename: J S
authors.initials: JS
authors.lastname: Hoffman
mesh_terms: D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial / Q000097:blood; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000201:enzymology / Q000276:immunology* / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008875:Middle Aged; D054328:Proton Pump Inhibitors; D012680:Sensitivity and Specificity; D014510:Urease / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D054328:Proton Pump Inhibitors; D014510:Urease